Inventory-Tracking Claims Held Unpatentable in a Covered Business Method Patent Review

Jul 28, 2016

Reading Time : 1 min

The PTAB then ruled that the claims at issue are not exempt from the CBM review based on the technological inventions exception.  To qualify for the exception, the claims must both (1) recite a technological feature that is novel and unobvious over the prior art and (2) solve a technical problem using a technical solution. Regarding the first prong, the PTAB found that the technological features, such as the database system, software and computer, were all well-known. Regarding the second prong, the PTAB held that inventory tracking and updating are not technical problems. Further, there is no “technical solution” because the patent provides no improvement on the technical components themselves. Accordingly, the PTAB found that the patent at issue is a CBM patent. 

The PTAB then went on to analyze the issue of unpatentability under § 101. Under the two-prong Alice framework, the PTAB considers (1) whether the claims are directed to a patent-ineligible concept and (2) whether there is an inventive concept that transforms the nature of the claims into a patent-eligible application. The PTAB concluded that the claims are directed to the abstract idea of managing inventory in view of information. Further, the claimed software, database, and computer were all well-known at the time of the invention. Thus, the PTAB found all asserted claims unpatentable under § 101. 

Life Techs. Corp. v. Unisone Strategic IP, Inc., Case CBM2015-00037 (PTAB June 28, 2016). [Bonila (opinion), Jung, and Powell]

 

Share This Insight

Previous Entries

IP Newsflash

July 22, 2026

The Court of Federal Claims recently denied the United States’ motion to dismiss a patent infringement suit related to production of a COVID-19 vaccine. The court held that it had jurisdiction because the plaintiff filed its claim there before it filed a parallel suit in a district court and because it adequately pleaded the government’s involvement.

...

Read More

IP Newsflash

July 13, 2026

In a precedential and sua sponte Director Review decision, USPTO Director Squires recently vacated three related institution decisions nearly six months after institution where a district court later found the challenged claims invalid. Because the fourteen-day deadline to request Director Review of the institution decisions had passed, the Director used this opportunity to formally extend the deadline in two ways. First, he extended the fourteen-day deadline under 37 C.F.R. § 42.75(c)(1) to thirty days, which “puts requests for Director Review of decisions to institute trial on equal footing to requests for Director Review of final decisions or decisions not to institute trial.” Second, he outlined certain “exceptional circumstances” that warrant a further extension of the deadline to account for changes in the case that “surface after the deadline.” In the case at hand, the Director found the district court’s invalidity finding to be such an “exceptional circumstance” and ultimately initiated review and vacated the institution decisions on that basis.

...

Read More

IP Newsflash

June 5, 2026

The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a generic drug has a skinny label, to induce infringement of the carved-out patented use of the drug, the generic company must have taken steps that were designed to cause others to perform the patented use, not just steps that could cause such conduct.

...

Read More

IP Newsflash

May 07, 2026

The Northern District of Illinois granted a summary judgment motion of no invalidity based on indefiniteness because the qualitative terms like “sufficiently slow” and “desired period of time” were definite when viewed in light of the surrounding claim language and specification.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.